On July 17, Marsh rose 3.43% in regular trading, trading at approximately $182.27/share, with turnover of $2.35 billion. The rally was driven by broad-based strength across the insurance brokerage sector combined with multiple analyst target price upgrades.

On the sector front, peers rallied in tandem, with Ryan Specialty up 4.43%, Brown & Brown up 3.93%, Aon up 3.56%, and Willis Towers Watson up 3.24%. At the company level, JPMorgan recently raised its target price from $206 to $212 while maintaining an Overweight rating, and UBS lifted its target to $212 from $203 with a Buy rating. Additionally, the company announced a 10% quarterly dividend increase to $0.99 per share on July 9, signaling management confidence in earnings sustainability ahead of its Q2 earnings release scheduled for July 21.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)